Team:BostonU/Workflow

From 2014.igem.org

(Difference between revisions)
 
(15 intermediate revisions not shown)
Line 13: Line 13:
   
   
       <tr>
       <tr>
-
         <td scope="col" colspan="2"><h2>Phase I - Build and test basic parts.</h2>
+
         <td scope="col" colspan="2">
 +
<center><img src="https://static.igem.org/mediawiki/2014/1/1a/BU14_DBTcycle.png" width="40%"></center>
 +
<br>
 +
For a detailed example of our Chimera Characterization Workflow, please check out the <a href="https://2014.igem.org/Team:BostonU/ChimeraExample">Chimera Example</a> page. Below, we present a brief outline of the major steps involved in each stage (Design, Build, Test) of the Chimera workflow, along with a few high level examples. We also define what we consider Phase I, II, and III to be for our workflow.
 +
<br><br>
 +
 
 +
<h2>Phase I - Build and test basic parts.</h2>
           Key software tools: TASBE Tools, Eugene (optional), Raven (optional)
           Key software tools: TASBE Tools, Eugene (optional), Raven (optional)
</td></tr>       
</td></tr>       
Line 31: Line 37:
<td scope="col" class="tableborderleft" style="padding-left: 15px">
<td scope="col" class="tableborderleft" style="padding-left: 15px">
-
• Add parts to <a href="https://2014.igem.org/Team:BostonU/MoClo">MoClo library</a>. These parts were found to be necessary for our priority encoder:<br><br>
+
• Add parts to <a href="https://2014.igem.org/Team:BostonU/MoClo">MoClo library</a>. The following parts were found to be necessary for our priority encoder:<br><br>
<p class="tab">• 3 MoClo level 1 and 3 MoClo level 2 backbones, each with a different <a href="https://2014.igem.org/Team:BostonU/Backbones">origin of replication</a>:<br></p>
<p class="tab">• 3 MoClo level 1 and 3 MoClo level 2 backbones, each with a different <a href="https://2014.igem.org/Team:BostonU/Backbones">origin of replication</a>:<br></p>
Line 54: Line 60:
• pBad_pTet<br>
• pBad_pTet<br>
</p>
</p>
-
These parts were cloned into a <i>E. coli</i> Bioline strain using our MoClo and transformation protocols. They were purified, sequenced, and tested using our FACS Workflow. These parts were then cloned into appropriate vectors and tested in our Fortessa flow cytometer. The TASBE Tools were then employed to characterize their expression.
+
These parts were cloned into a <i>E. coli</i> Bioline strain using our MoClo and transformation protocols. They were purified and sequenced. Additionally, we built testing devices for each of the new parts. Details can be found on the <a href="https://2014.igem.org/Team:BostonU/FusionProteins">fusion proteins </a>, <a href="https://2014.igem.org/Team:BostonU/ProjectTandemPromoters">tandem promoters </a>, and <a href="https://2014.igem.org/Team:BostonU/Backbones">origin of replication</a> project pages. We tested these using our <a href="https://static.igem.org/mediawiki/2014/7/7c/Flow_Cytometer_WorkflowYABU.xls">FACS Workflow</a> and our BD LSRFortessa flow cytometer.The TASBE Tools were then employed to characterize their expression.
</td>
</td>
Line 60: Line 66:
<tr>
<tr>
 +
<br><br>
         <td scope="col" colspan="2"><h2>Phase II - Build and characterize TU behavior.</h2>
         <td scope="col" colspan="2"><h2>Phase II - Build and characterize TU behavior.</h2>
           Key software tools: TASBE Tools, Eugene, Raven
           Key software tools: TASBE Tools, Eugene, Raven
Line 77: Line 84:
<td scope="col" class="tableborderleft" style="padding-left: 15px">
<td scope="col" class="tableborderleft" style="padding-left: 15px">
-
• Run one-pot Multiplexing MoClo reaction. We initially multiplexed 5' UTIs and Terminators<br>
+
• Run one-pot <a href="https://2014.igem.org/Team:BostonU/Multiplexing">Multiplexing MoClo reaction</a>. We initially multiplexed RBSs.
<p class="tab">• Eugene was employed to visualize all possible part substitutions.<br>
<p class="tab">• Eugene was employed to visualize all possible part substitutions.<br>
• Raven was employed to optimize the assembly of these combinations.</p><br><br>
• Raven was employed to optimize the assembly of these combinations.</p><br><br>
Line 86: Line 93:
<tr>
<tr>
 +
<br><br>
         <td scope="col" colspan="2"><h2>Phase III - Test regulatory arcs and assemble final device.</h2>
         <td scope="col" colspan="2"><h2>Phase III - Test regulatory arcs and assemble final device.</h2>
           Key software tools: TASBE Tools, Eugene, Raven
           Key software tools: TASBE Tools, Eugene, Raven
Line 98: Line 106:
<tr>
<tr>
         <td scope="col">
         <td scope="col">
-
•      Test every possible combination of the transcriptional units chosen from Phase 2 to test individual regulatory arcs using flow cytometry<br><br>
+
<center><img src="https://static.igem.org/mediawiki/2014/2/29/Phase_III_Chimera_updated.png" width="100%"></center>
-
• Use Raven and Eugene in this phase to allow for efficient design of the complex device and decide which building strategy would work best to test the relationship between two or more transcriptional units<br><br>
+
 
-
• Testing several pairs of units with varying concentrations of small molecule induction is always a good idea so that a large range of data can be collected. This data will then be analyzed to gauge the efficacy of the device.
+
</td>
</td>
<td scope="col" class="tableborderleft" style="padding-left: 15px">
<td scope="col" class="tableborderleft" style="padding-left: 15px">
-
• Test individual TU regulatory arcs:<br>
+
• Test individual TU regulatory arcs<br>
-
<p class="tab">• ...<br></p>
+
• Use Eugene to plan final device topology.<br><br>
• Use Eugene to plan final device topology.<br><br>
• Use Raven to guide MoClo assembly of encoder.<br><br>
• Use Raven to guide MoClo assembly of encoder.<br><br>

Latest revision as of 02:44, 18 October 2014



Workflow




For a detailed example of our Chimera Characterization Workflow, please check out the Chimera Example page. Below, we present a brief outline of the major steps involved in each stage (Design, Build, Test) of the Chimera workflow, along with a few high level examples. We also define what we consider Phase I, II, and III to be for our workflow.

Phase I - Build and test basic parts.

Key software tools: TASBE Tools, Eugene (optional), Raven (optional)

General Chimera Workflow

Case Study: BU Priority Encoder

• Add parts to MoClo library. The following parts were found to be necessary for our priority encoder:

• 3 MoClo level 1 and 3 MoClo level 2 backbones, each with a different origin of replication:

• ColE1
• p15A
• pSC101

• 4 MoClo level 0 fusion proteins:

tetR_GFP
tetR_YFP
araC_YFP
araC_GFP


• X MoClo level 0 tandem promoters:

• pTet_pBad
• pBad_pTet

These parts were cloned into a E. coli Bioline strain using our MoClo and transformation protocols. They were purified and sequenced. Additionally, we built testing devices for each of the new parts. Details can be found on the fusion proteins , tandem promoters , and origin of replication project pages. We tested these using our FACS Workflow and our BD LSRFortessa flow cytometer.The TASBE Tools were then employed to characterize their expression.

Phase II - Build and characterize TU behavior.

Key software tools: TASBE Tools, Eugene, Raven

General Chimera Workflow

Case Study: BU Priority Encoder

• Run one-pot Multiplexing MoClo reaction. We initially multiplexed RBSs.

• Eugene was employed to visualize all possible part substitutions.
• Raven was employed to optimize the assembly of these combinations.



• Clone multiplexed reactions into Pro strain of E. coli using Pro Transformation protocol.

• Pick 20 colonies per plate, purify, and sequence.

• Test using flow cytometry workflow and analyze data using the TASBE Tools.

Phase III - Test regulatory arcs and assemble final device.

Key software tools: TASBE Tools, Eugene, Raven

General Chimera Workflow

Case Study: BU Priority Encoder

• Test individual TU regulatory arcs
• Use Eugene to plan final device topology.

• Use Raven to guide MoClo assembly of encoder.

• Clone multiplexed reactions into Pro strain of E. coli using Pro Transformation protocol.

• Pick colonies, purify, and sequence.

• Test using flow cytometry workflow and analyze data using the TASBE Tools.








Our Sponsors

Retrieved from "http://2014.igem.org/Team:BostonU/Workflow"